Table 1 Summary of patient characteristics

No. of participants

30

Median age (interquartile range), years

66.5 (56–71)

Sex, n

 Male

22

 Female

8

ECOG score

 0

19

 1

11

T stage

 T2

1

 T3

24

 T4

5

N stage

 N0

6

 N1

16

 N2

8

Median radiotherapy dose (interquartile range), Gy

59.9 (54–60)

Chemotherapy regimen

 Docetaxel + Carboplatin/Nedaplatin

4

 Paclitaxel + Nedaplatin/Carboplatin/Cisplatin

16

 Paclitaxel

7

 Capecitabine

1

 Tegafur

2